Expression of Decorin in Esophageal Cancer in Relation to the Expression of Three Isoforms of Transforming Growth Factor-Beta (TGF-β1, -β2, and -β3) and Matrix Metalloproteinase-2 Activity

REFERENCES

• Ilson D. H. Oesophageal cancer: new developments in systemic therapy. Cancer Treat Rev 2003; 29: 525–532
   PubMed Web of Science ®Google Scholar
• Ingber D. E. Cancer as a disease of epithelial-mesenchymal interactions and extracellular matrix regulation. Differentiation 2002 Dec; 70(9–10)547–560, Review
   PubMed Web of Science ®Google Scholar
• Pupa S. M., Menard S., Forti S., Tagliabue E. New insights into the role of extracellular matrix during tumor onset and progression. J Cell Physiol 2002 Sep; 192(3)259–267
   PubMed Web of Science ®Google Scholar
• Streuli C. H., Schmidhauser C., Kobrin M., Bissell M. J., Derynck R. Extracellular matrix regulates expression of the TGF-beta 1 gene. J Cell Biol 1993 Jan; 120(1)253–260
   PubMed Web of Science ®Google Scholar
• Desoize B. Stromal reaction and tumour growth. Crit Rev Oncol Hematol Mar, 2004; 49(3)173–176
   PubMed Web of Science ®Google Scholar
• Wegrowski Y., Maquart F. X. Involvement of stromal proteoglycans in tumour progression. Crit Rev Oncol Hematol Mar, 2004; 49(3)259–268
   PubMed Web of Science ®Google Scholar
• Kresse H., Schonherr E. Proteoglycans of the extracellular matrix and growth control. J Cell Physiol Dec, 2001; 189(3)266–274
   PubMed Web of Science ®Google Scholar
• Goldoni S., Owens R. T., McQuillan D. J., Shriver Z., Sasisekharan R., Birk D. E., Campbell S., Iozzo R. V. Biologically active decorin is a monomer in solution. J Biol Chem Feb 20, 2004; 279(8)6606–6612
   PubMed Web of Science ®Google Scholar
• Scott P. G., Dodd C. M., Bergmann E. M., Sheehan J. K., Bishop P. N. Crystal structure of the biglycan dimer and evidence that dimerization is essential for folding and stability of class I small leucine-rich repeat proteoglycans. J Biol Chem May 12, 2006; 281(19)13324–13332, Epub 2006 Mar 17
   PubMed Web of Science ®Google Scholar
• Font B., Aubert-Foucher E., Goldschmidt D., Eichenberger D., van der Rest M. Binding of collagen XIV with the dermatan sulfate side chain of decorin. J Biol Chem Nov 25, 1993; 268(33)25015–25018
   PubMed Web of Science ®Google Scholar
• Font B., Eichenberger D., Rosenberg L. M., van der Rest M. Characterization of the interactions of type XII collagen with two small proteoglycans from fetal bovine tendon, decorin and fibromodulin. Matrix Biol Nov, 1996; 15(5)341–348
   PubMed Web of Science ®Google Scholar
• Kinsella M. G., Fischer J. W., Mason D. P., Wight T. N. Retrovirally mediated expression of decorin by macrovascular endothelial cells. Effects on cellular migration and fibronectin fibrillogenesis in vitro. J Biol Chem May 5, 2000; 275(18)13924–13932
   PubMed Web of Science ®Google Scholar
• Geng Y., McQuillan D., Roughley P. J. SLRP interaction can protect collagen fibrils from cleavage by collagenases. Matrix Biol Oct, 2006; 25(8)484–491, Epub 2006 Aug 15
   PubMed Web of Science ®Google Scholar
• Rühland C., Schönherr E., Robenek H., Hansen U., Iozzo R. V., Bruckner P., Seidler D. G. The glycosaminoglycan chain of decorin plays an important role in collagen fibril formation at the early stages of fibrillogenesis. FEBS J Aug, 2007; 274(16)4246–4255
   PubMed Web of Science ®Google Scholar
• Reed C. C., Iozzo R. V. The role of decorin in collagen fibrillogenesis and skin homeostasis. Glycoconj J. May–Jun, 2002; 19(4–5)249–255
   PubMed Web of Science ®Google Scholar
• Iozzo R. V., Moscatello D. K., McQuillan D. J., Eichstetter I. Decorin is a biological ligand for the epidermal growth factor receptor. J Biol Chem Feb 19, 1999; 274(8)4489–4492
   PubMed Web of Science ®Google Scholar
• De Luca A., Santra M., Baldi A., Giordano A., Iozzo R. V. Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases. J Biol Chem Aug 2, 1996; 271(31)18961–18965
   PubMed Web of Science ®Google Scholar
• Moscatello D. K., Santra M., Mann D. M., McQuillan D. J., Wong A. J., Iozzo R. V. Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J Clin Invest Jan 15, 1998; 101(2)406–412
   PubMed Web of Science ®Google Scholar
• Imai K., Hiramatsu A., Fukushima D., Pierschbacher M. D., Okada Y. Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem J. Mar 15, 1997; 322(Pt 3)809–814
   PubMedGoogle Scholar
• Schönherr E., Broszat M., Brandan E., Bruckner P., Kresse H. Decorin core protein fragment Leu155-Val260 interacts with TGF-beta but does not compete for decorin binding to type I collagen. Arch Biochem Biophys Jul 15, 1998; 355(2)241–248
   PubMed Web of Science ®Google Scholar
• Santra M., Skorski T., Calabretta B., Lattime E. C., Iozzo R. V. De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. Proc Natl Acad Sci. USA Jul 18, 1995; 92(15)7016–7020
   PubMed Web of Science ®Google Scholar
• Järveläinen H., Puolakkainen P., Pakkanen S., Brown E. L., Höök M., Iozzo R. V., Sage E. H., Wight T. N. A role for decorin in cutaneous wound healing and angiogenesis. Wound Repair Regen Jul–Aug, 2006; 14(4)443–452
   PubMed Web of Science ®Google Scholar
• Leygue E., Snell L., Dotzlaw H., Troup S., Hiller-Hitchcock T., Murphy L. C., Roughley P. J., Watson P. H. Lumican and decorin are differentially expressed in human breast carcinoma. J Pathol Nov, 2000; 192(3)313–320
   PubMed Web of Science ®Google Scholar
• Harada T., Shinohara M., Nakamura S., Oka M. An immunohistochemical study of the extracellular matrix in oral squamous cell carcinoma and its association with invasive and metastatic potential. Virchows Arch 1994; 24: 257–266
   Google Scholar
• Troup S., Njue C., Kliewer E. V., Parisien M., Roskelley C., Chakravarti S., Roughley P. J., Murphy L. C., Watson P. H. Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin Cancer Res Jan, 2003; 9(1)207–214
   PubMed Web of Science ®Google Scholar
• Banerjee A. G., Bhattacharyya I., Lydiatt W. M., Vishwanatha J. K. Aberrant expression and localization of decorin in human oral dysplasia and squamous cell carcinoma. Cancer Res Nov 15, 2003; 63(22)7769–7776
   PubMed Web of Science ®Google Scholar
• Bellone G., Carbone A., Tibaudi D., Mauri F., Ferrero I., Smirne C., Suman F., Rivetti C., Migliaretti G., Camandona M., Palestro G., Emanuelli G., Rodeck U. Differential expression of transforming growth factors-beta1, -beta2 and -beta3 in human colon carcinoma. Eur J. Cancer Jan, 2001; 37(2)224–233
   PubMed Web of Science ®Google Scholar
• Shekhar M. P., Pauley R., Heppner G. Host microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast. Breast Cancer Res 2003; 5(3)130–135
   PubMed Web of Science ®Google Scholar
• De Wever O., Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol Jul, 2003; 200(4)429–447
   PubMed Web of Science ®Google Scholar
• Koninger J., Giese T., di Mola F. F., Wente M. N., Esposito I., Bachem M. G., Giese N. A., Buchler M. W., Friess H. Pancreatic tumor cells influence the composition of the extracellular matrix. Biochem Biophys Res Commun Sep 24, 2004; 322(3)943–949
   PubMed Web of Science ®Google Scholar
• Adany R., Heimer R., Caterson B., Sorrell J. M., Iozzo R. V. Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. Hypomethylation of PG-40 gene correlates with increased PG-40 content and mRNA levels. J Biol Chem Jul 5, 1990; 265(19)11389–11396
   PubMed Web of Science ®Google Scholar
• Matsumine A., Shintani K., Kusuzaki K., Matsubara T., Satonaka H., Wakabayashi T., Iino T., Uchida A. Expression of decorin, a small leucine-rich proteoglycan, as a prognostic factor in soft tissue tumors. J Surg Oncol Oct 1, 2007; 96(5)411–418
   PubMed Web of Science ®Google Scholar
• Iozzo R. V., Wight T. N. Isolation and characterization of proteoglycans synthesized by human colon and colon carcinoma. J Biol Chem Sep 25, 1982; 257(18)11135–11144
   PubMedGoogle Scholar
• Reed C. C., Waterhouse A., Kirby S., Kay P., Owens R. T., McQuillan D. J., Iozzo R. V. Decorin prevents metastatic spreading of breast cancer. Oncogene Feb 3, 2005; 24(6)1104–1110
   PubMed Web of Science ®Google Scholar
• Seidler D. G., Goldoni S., Agnew C., Cardi C., Thakur M. L., Owens R. T., McQuillan D. J., Iozzo R. V. Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation. J Biol Chem Sep 8, 2006; 281(36)26408–26418
   PubMed Web of Science ®Google Scholar
• Nash M. A., Deavers M. T., Freedman R. S. The expression of decorin in human ovarian tumors. Clin Cancer Res Jun, 2002; 8(6)1754–1760
   PubMed Web of Science ®Google Scholar
• Brezillon S., Venteo L., Ramont L., D'Onofrio M. F., Perreau C., Pluot M., Maquart F. X., Wegrowski Y. Expression of lumican, a small leucine-rich proteoglycan with antitumour activity, in human malignant melanoma. Clin Exp Dermatol Jul, 2007; 32(4)405–416, Epub 2007 May 8
   PubMed Web of Science ®Google Scholar
• Hildebrand A., Romaris M., Rasmussen L. M., Heinegard D., Twardzik D. R., Border W. A., Ruoslahti E. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J. Sep 1, 1994; 302(Pt 2)527–534
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y., Mann D. M., Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature Jul 19, 1990; 346(6281)281–284
   PubMed Web of Science ®Google Scholar
• Chin D., Boyle G. M., Parsons P. G., Coman W. B. What is transforming growth factor-beta (TGF-beta)?. Br. J. Plast Surg Apr, 2004; 57(3)215–221, Review
   PubMedGoogle Scholar
• de Caestecker M. P., Piek E., Roberts A. B. Role of transforming growth factor-beta signaling in cancer. J Natl Cancer Inst Sep 6, 2000; 92(17)1388–1402
   PubMed Web of Science ®Google Scholar
• Ma C., Tarnuzzer R. W., Chegini N. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in mesothelial cells and their regulation by transforming growth factor-beta1. Wound Repair Regen Nov–Dec, 1999; 7(6)477–485
   PubMed Web of Science ®Google Scholar